Edition:
United States

Health News

Mylan recalls batches of blood pressure medicine in U.S.

Mylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a probable cancer-causing impurity, the latest recall amid heightened safety concerns globally.

Health Reform Watch